Related Experiment Videos
Summary
Peritoneal dialysis (PD) offers a viable home treatment alternative for patients with kidney failure, especially those facing remote situations or vascular access issues. This study shows PD
Area of Science:
- Nephrology
- Renal Replacement Therapy
Background:
- Developed a parallel peritoneal dialysis (PD) program in March 1972 as an alternative to home hemodialysis (HD).
- Aimed to provide home dialysis for patients with remote locations or vascular access failure.
Observation:
- 36 patients initiated PD for home treatment over four years.
- 30 patients succeeded in home treatments, with 22 completing at least six months.
- Seven patients were treated for over one year.
Findings:
- No neuropathy observed, except in diabetic patients.
- No patient required blood transfusions, even post-nephrectomy.
- Slightly higher predialysis serum creatinine noted in prior HD patients (p<0.07).
- Lower serum albumin in PD patients compared to HD (3.3 vs 3.8 g/100 ml, p<0.05).
- Bacterial peritonitis occurred in 16/36 patients (22 episodes, incidence 1/14 months).
- Sterile peritonitis epidemic (40 episodes) resolved by changing machine techniques.
- Catheter failure in 15/22 long-term patients, but replacement was manageable.
Implications:
- Peritoneal dialysis is a feasible home treatment option for select kidney failure patients.
- PD can eliminate the need for transfusions in many patients.
- Careful technique and monitoring are crucial to manage peritonitis risks.
- Catheter complications are manageable, supporting PD's long-term viability.